Skip to main content
RDNT
NASDAQ Life Sciences

RadNet Plans $200M Incremental Term Loan

Reported by Dow Jones Newswires
Sentiment info
Neutral
Importance info
7
Price
$54.31
Mkt Cap
$4.271B
52W Low
$50.76
52W High
$85.84
Market data snapshot near publication time

Summary

RadNet is seeking to secure an additional $200 million incremental term loan. This financing move follows the company's recent report of record first-quarter 2026 financial results, which highlighted significant revenue growth and strategic acquisitions. The new debt could be used to fund further growth initiatives, including potential acquisitions, or to enhance the company's overall financial flexibility. This represents a material addition to RadNet's capital structure.

At the time of this announcement, RDNT was trading at $54.31 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $50.76 to $85.84. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

RDNT - Latest Insights

RDNT
Jun 03, 2026, 8:07 AM EDT
Filing Type: 8-K
Importance Score:
8
RDNT
Jun 03, 2026, 8:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
RDNT
May 11, 2026, 4:40 PM EDT
Filing Type: 10-Q
Importance Score:
8
RDNT
May 11, 2026, 7:24 AM EDT
Filing Type: 8-K
Importance Score:
8
RDNT
May 10, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
9
RDNT
May 04, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
RDNT
Apr 20, 2026, 5:15 PM EDT
Filing Type: DEF 14A
Importance Score:
7
RDNT
Mar 02, 2026, 5:25 PM EST
Source: Wiseek News
Importance Score:
8
RDNT
Mar 02, 2026, 5:17 PM EST
Filing Type: 10-K
Importance Score:
8
RDNT
Mar 02, 2026, 7:01 AM EST
Filing Type: 8-K
Importance Score:
8